Reversibility of liver failure secondary to metastatic breast cancer by vinorelbine and cisplatin chemotherapy

被引:0
|
作者
Ricky A. Sharma
Marios P. Decatris
Sundar Santhanam
Rajarshi Roy
Ahmed E. Osman
Christine B. Clarke
Subhash Khanna
Kenneth J. O'Byrne
机构
[1] University Hospitals of Leicester,Department of Oncology, Leicester Royal Infirmary
来源
关键词
Jaundice; Palliation; Platinum; Vinca;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:367 / 370
页数:3
相关论文
共 50 条
  • [31] Efficacy and Safety of Vinorelbine Plus Cisplatin vs. Gemcitabine Plus Cisplatin for Treatment of Metastatic Triple-Negative Breast Cancer After Failure with Anthracyclines and Taxanes
    Wang, Junbin
    Zheng, Rongsheng
    Wang, Zishu
    Yang, Yan
    Wang, Mingxi
    Zou, Weiyan
    MEDICAL SCIENCE MONITOR, 2017, 23 : 4657 - 4664
  • [32] Vinorelbine and cisplatin for metastatic breast cancer: A salvage regimen in patients progressing after docetaxel and anthracycline treatment
    Vassilomanolakis, M
    Koumakis, G
    Demiri, M
    Missitzis, J
    Barbounis, V
    Efremidis, AP
    CANCER INVESTIGATION, 2003, 21 (04) : 497 - 504
  • [33] INTENSIVE CHEMOTHERAPY WITH CISPLATIN, MITOXANTRONE, METHOTREXATE AND VINCRISTINE IN METASTATIC BREAST-CANCER
    QUEIROLO, P
    REPETTO, L
    GARDIN, G
    MIGLIETTA, L
    GUIDO, T
    PRONZATO, P
    ROSSO, R
    JOURNAL OF CHEMOTHERAPY, 1991, 3 (03) : 194 - 197
  • [34] Palliative chemotherapy with vinorelbine or capecitabine in women with anthracycline and taxane refractory metastatic breast cancer.
    Clemons, MJ
    Verma, S
    Leung, V
    Dranitsaris, G
    Shalaby, I
    Oldfield, S
    Charbonneau, F
    Giotis, A
    Petrella, T
    Trudeau, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 70S - 70S
  • [35] Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck
    Hong, Min Hee
    Kim, Chang Gon
    Koh, Yoon Woo
    Choi, Eun Chang
    Kim, Jinna
    Yoon, Sun Och
    Kim, Hye Ryun
    Cho, Byoung Chul
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (01): : 55 - 62
  • [36] Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines
    Martí, JL
    Bueso, P
    Mayordomo, JI
    Isla, MD
    Saenz, A
    Escudero, P
    Murillo, L
    Filipovich, E
    Andres, R
    Tres, A
    ANNALS OF ONCOLOGY, 2001, 12 (08) : 1061 - 1065
  • [37] Vinorelbine, 5 fluorouracil, leucovorin and cyclophosphamide as first line chemotherapy in metastatic breast cancer (MBC)
    Turpin, E
    Lluch, A
    Closon, MH
    Gruia, G
    Llombart, A
    Fernandez, R
    Delgado, FM
    Martinez, A
    GarciaConde, J
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 374 - 374
  • [38] CHEMOTHERAPY WITH CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE (CAP) IN PATIENTS WITH METASTATIC BREAST-CANCER
    COLOZZA, M
    GORI, S
    MOSCONI, AM
    BELSANTI, V
    BASURTO, C
    ROSSETTI, R
    DICOSTANZO, F
    BUZZI, F
    BACCHI, M
    DAVIS, S
    TONATO, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (02): : 137 - 141
  • [39] Epirubicin and vinorelbine versus single agent epirubicin as first line chemotherapy in metastatic breast cancer
    Ejlertsen, B
    Mouridsen, H
    Langkjer, ST
    Andersen, J
    Sjostrom, J
    Kjaer, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S66 - S67
  • [40] Cisplatin plus oral vinorelbine as first line chemotherapy in patients with triple negative advanced breast cancer
    Wahab, M. Moawad Abdel
    Elarab, L. Ezz
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S283 - S283